Literature DB >> 20666081

Reimbursement of new high cost drugs--funding the unfundable?

M Barry, L Tilson.   

Abstract

Mesh：

Year:  2010        PMID： 20666081

Source DB:  PubMed          Journal:  Ir Med J        ISSN： 0332-3102


× No keyword cloud information.
  3 in total

1.  Optimizing pharmacotherapy in older patients: a European perspective.

Authors:  Denis O'Mahony; Antonio Cherubini; Mirko Petrovic
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  Ageing, health status and coverage rate effects on community prescription costs in Ireland.

Authors:  Martin Kenneally; Brenda Lynch
Journal:  Eur J Health Econ       Date:  2017-06-21

3.  Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis.

Authors:  Rick A Vreman; Thomas F Broekhoff; Hubert Gm Leufkens; Aukje K Mantel-Teeuwisse; Wim G Goettsch
Journal:  Int J Environ Res Public Health       Date:  2020-11-10       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.